USPTO serial 79296099
MYIPS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 23, 2021
- Examiner
- WINTER, MELISSA S
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with MYIPS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,795*
Plus Government fees of $1,625
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Dawn Rudenko
Dawn Rudenko Holland & Knight LLP263 Tresser BlvdOne Stamford Plaza, Ste1400Stamford, CT 06901Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Stem cells for research and scientific purposes; stem cells, other than for medical or veterinary purposes; industrial chemicals; chemical test paper, other than for medical purposes; cell culture reagents for laboratory use; cell culture media for scientific or research purposes; biological preparation for use in cell cultures other than for medical or veterinary use | ACTIVE | — |
| 005 | Stem cells for medical and clinical purposes; pharmaceutical preparations for use in regenerative therapy; test paper being reagent paper for medical purposes; living cells for medical use; cells for medical use; tissues for medical use, namely, biological tissue cultures for medical purposes | ACTIVE | — |
| 039 | Storage of frozen living cells; storage of biological tissues, cells and stem cells; warehousing services for deposited articles | ACTIVE | — |
| 042 | Scientific research on stem cells; cell culture services for scientific and research purposes, for others; cytogenetic examination for research purposes; scientific testing, examination for medical research purposes, research and development in the field of cytology; scientific testing, examination for medical research purposes, research and development in the field of regenerative medicine; testing, examination, research and development of pharmaceuticals; conducting clinical studies for others; medical laboratory services; providing quality assurance in the field of cells; quality control for others; providing information on medical research in the field of medical therapy; providing information on medical research and testing for medical research purposes related to stem cells; providing information related to research and development of pharmaceutical preparations; scientific testing, examination for medical research purposes and research of medical therapy methods and technologies; testing, examination and research of cosmetics and foods; design and development of computer hardware and computer software for use in the field of medical science; design and development of machines, apparatus, instruments and systems in the field of medical science; design, development and maintenance of computer programs; testing the functionality of and performing research on machines, apparatus, and instruments in the field of medical science; rental of laboratory apparatus and instruments | ACTIVE | — |
| 044 | Stem cell therapy services; providing medical information in the field of cells; providing medical information on regenerative medicine; providing medical information; collection and preservation of biological tissues, blood and cells; medical treatment and diagnosis services in the nature of regenerative therapy by using a cell culture ; cell culture bank services for medical transplantation ; medical care; providing information and data for medical diagnosis and treatment; medical treatment and diagnosis in the nature of regenerative therapy by regenerative medicine; medical cell therapy and diagnosis services in the nature of regenerative cell therapy; medical treatment and consulting services in the nature of regenerative cell therapy by cell preparations; preservation of human blood for stem cells; providing medical information and medical record analysis for use in medical treatment ; clinical medical examination services; providing health care services; preparation and dispensing of medications; physical examination services; dentistry services; providing health information; dietary and nutritional guidance; rental of medical apparatus and instruments | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CiRA Foundation
- Other trademarks owned by CiRA Foundation
- Other trademarks owned by CiRA Foundation
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 039
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named MYIPS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 6, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 12, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 11, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 23, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 26, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Nov 23, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 7, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 7, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 5, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 18, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 18, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 18, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 2, 2021 | ALIE | ASSIGNED TO LIE | — |
| Aug 2, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 2, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 2, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 2, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 2, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 14, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 14, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 14, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 1, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 7, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 7, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 29, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 28, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 19, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 23, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 19, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 19, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 15, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |